| First Author | Lou Y | Year | 2020 |
| Journal | J Immunol | Volume | 204 |
| Issue | 8 | Pages | 2122-2132 |
| PubMed ID | 32188758 | Mgi Jnum | J:287611 |
| Mgi Id | MGI:6406061 | Doi | 10.4049/jimmunol.1901142 |
| Citation | Lou Y, et al. (2020) The SCF(beta-TrCP) E3 Ubiquitin Ligase Regulates Immune Receptor Signaling by Targeting the Negative Regulatory Protein TIPE2. J Immunol 204(8):2122-2132 |
| abstractText | TNFAIP8-like 2 (TIPE2) is a negative regulator of immune receptor signaling that maintains immune homeostasis. Dysregulated TIPE2 expression has been observed in several types of human immunological disorders. However, how TIPE2 expression is regulated remains to be determined. We report in this study that the SCF(beta-TrCP) E3 ubiquitin ligase regulates TIPE2 protein abundance by targeting it for ubiquitination and subsequent degradation via the 26S proteasome. Silencing of either cullin-1 or beta-TrCP1 resulted in increased levels of TIPE2 in immune cells. TAK1 phosphorylated the Ser(3) in the noncanonical degron motif of TIPE2 to trigger its interaction with beta-TrCP for subsequent ubiquitination and degradation. Importantly, the amount of TIPE2 protein in immune cells determined the strength of TLR 4-induced signaling and downstream gene expression. Thus, our study has uncovered a mechanism by which SCF(beta-TrCP) E3 ubiquitin ligase regulates TLR responses. |
